Michael V. Knopp

20.0k total citations · 1 hit paper
358 papers, 14.0k citations indexed

About

Michael V. Knopp is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Biomedical Engineering. According to data from OpenAlex, Michael V. Knopp has authored 358 papers receiving a total of 14.0k indexed citations (citations by other indexed papers that have themselves been cited), including 248 papers in Radiology, Nuclear Medicine and Imaging, 80 papers in Pulmonary and Respiratory Medicine and 40 papers in Biomedical Engineering. Recurrent topics in Michael V. Knopp's work include MRI in cancer diagnosis (122 papers), Advanced MRI Techniques and Applications (118 papers) and Medical Imaging Techniques and Applications (73 papers). Michael V. Knopp is often cited by papers focused on MRI in cancer diagnosis (122 papers), Advanced MRI Techniques and Applications (118 papers) and Medical Imaging Techniques and Applications (73 papers). Michael V. Knopp collaborates with scholars based in United States, Germany and Italy. Michael V. Knopp's co-authors include Gunnar Brix, Marco Essig, Nina A. Mayr, Ruediger E. Port, G. van Kaick, Peter L. Choyke, Jeffrey L. Evelhoch, David L. Buckley, Paul S. Tofts and June S. Taylor and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Michael V. Knopp

349 papers receiving 13.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estimating kinetic parameters from dynamic contrast-enhanced t1-weighted MRI of a diffusable tracer: Standardized quantities and symbols

1999 2.5k citations Michael V. Knopp, Nina A. Mayr et al. Journal of Magnetic Resonance Imaging profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Michael V. Knopp	9.1k	2.4k	1.3k	1.2k	1.2k	358	14.0k
Thomas L. Chenevert	12.0k 1.3×	2.9k 1.2×	630 0.5×	1.2k 1.0×	1.6k 1.3×	290	17.4k
Hans H. Schild	8.7k 1.0×	3.0k 1.3×	615 0.5×	1.1k 0.8×	918 0.7×	560	18.4k
Arend Heerschap	6.6k 0.7×	2.3k 1.0×	1.2k 0.9×	1.7k 1.3×	3.5k 2.8×	380	14.1k
Michael E. Phelps	9.9k 1.1×	2.2k 0.9×	432 0.3×	1.3k 1.0×	2.0k 1.6×	195	17.8k
Paul S. Tofts	12.3k 1.4×	1.2k 0.5×	1.1k 0.9×	1.7k 1.4×	1.9k 1.5×	205	18.9k
Alan Jackson	6.2k 0.7×	2.0k 0.8×	410 0.3×	806 0.7×	986 0.8×	312	13.0k
Gunnar Brix	8.7k 1.0×	1.6k 0.7×	796 0.6×	1.7k 1.3×	679 0.5×	221	11.0k
Otmar Schober	3.4k 0.4×	1.8k 0.7×	704 0.5×	561 0.5×	1.1k 0.9×	353	9.2k
Ronald Boellaard	13.9k 1.5×	4.4k 1.9×	389 0.3×	2.5k 2.0×	1.4k 1.2×	599	20.7k
Junji Konishi	5.4k 0.6×	2.5k 1.1×	493 0.4×	854 0.7×	2.1k 1.7×	575	17.4k

Countries citing papers authored by Michael V. Knopp

Since Specialization

Citations

This map shows the geographic impact of Michael V. Knopp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael V. Knopp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael V. Knopp more than expected).

Fields of papers citing papers by Michael V. Knopp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael V. Knopp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael V. Knopp. The network helps show where Michael V. Knopp may publish in the future.

Co-authorship network of co-authors of Michael V. Knopp

This figure shows the co-authorship network connecting the top 25 collaborators of Michael V. Knopp. A scholar is included among the top collaborators of Michael V. Knopp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael V. Knopp. Michael V. Knopp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Viviani, Simonetta, Chiara Pavoni, Sally F. Barrington, et al.. (2025). Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials. Blood Cancer Journal. 15(1). 165–165.

Chan, Jennifer A., Susan M. Geyer, Tyler Zemla, et al.. (2024). 1141O Cabozantinib versus placebo for advanced neuroendocrine tumors (NET) after progression on prior therapy (CABINET Trial/Alliance A021602): Updated results including progression free-survival (PFS) by blinded independent central review (BICR) and subgroup analyses. Annals of Oncology. 35. S749–S749.

Chan, Jennifer A., Susan M. Geyer, Michael V. Knopp, et al.. (2023). LBA53 Alliance A021602: Phase III, double-blinded study of cabozantinib versus placebo for advanced neuroendocrine tumors (NET) after progression on prior therapy (CABINET). Annals of Oncology. 34. S1292–S1292. 18 indexed citations

Nyirjesy, Sarah C., et al.. (2023). Higher Computed Tomography (CT) Scan Resolution Improves Accuracy of Patient-specific Mandibular Models When Compared to Cadaveric Gold Standard. Journal of Oral and Maxillofacial Surgery. 81(9). 1176–1185. 3 indexed citations

Rosas, Lucia E., et al.. (2022). Cytidine 5′-Diphosphocholine Corrects Alveolar Type II Cell Mitochondrial Dysfunction in Influenza-infected Mice. American Journal of Respiratory Cell and Molecular Biology. 66(6). 682–693. 6 indexed citations

Schöder, Heiko, Mei‐Yin C. Polley, Michael V. Knopp, et al.. (2020). Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial. Blood. 135(25). 2224–2234. 63 indexed citations

Ha, Chul S., Michael LeBlanc, Heiko Schöder, et al.. (2020). Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816. Leukemia & lymphoma. 61(10). 2442–2447. 1 indexed citations

Stephens, Deborah M., Hongli Li, Heiko Schöder, et al.. (2019). Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma. Blood. 134(15). 1238–1246. 71 indexed citations

Wright, Chadwick, et al.. (2019). Enhancing Patient Experience With Internet Protocol Addressable Digital Light-Emitting Diode Lighting in Imaging Environments: A Phase I Study. Journal of Medical Internet Research. 22(6). e11839–e11839. 1 indexed citations

10.

Wright, Chadwick, et al.. (2017). Advanced Functional Tumor Imaging and Precision Nuclear Medicine Enabled by Digital PET Technologies. Contrast Media & Molecular Imaging. 2017. 1–7. 32 indexed citations

11.

Bowen, Stephen R., William T. C. Yuh, Daniel S. Hippe, et al.. (2017). Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy. Journal of Magnetic Resonance Imaging. 47(5). 1388–1396. 87 indexed citations

12.

Borniger, Jeremy C., Michelle M. Williams, Michael F. Tweedle, et al.. (2016). Photoperiod Affects Organ Specific Glucose Metabolism in Male Siberian Hamsters (Phodopus sungorus). 1(2). 2 indexed citations

13.

Mrózek, Ewa, Rachel M. Layman, Bhuvaneswari Ramaswamy, et al.. (2014). Phase II Trial of Neoadjuvant Weekly Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Biweekly Bevacizumab Therapy in Women With Clinical Stage II or III HER2-Negative Breast Cancer. Clinical Breast Cancer. 14(4). 228–234. 29 indexed citations

14.

Kloos, Richard T., Matthew D. Ringel, Michael V. Knopp, et al.. (2009). Phase II Trial of Sorafenib in Metastatic Thyroid Cancer. Journal of Clinical Oncology. 27(10). 1675–1684. 430 indexed citations

15.

Hall, Nathan C., et al.. (2007). FDG-PET scan in patients with clinically and/or radiologically suspicious colorectal cancer recurrence but normal CEA. SHILAP Revista de lepidopterología. 38 indexed citations

16.

Clymer, Bradley D., et al.. (2005). Dynamic contrast enhanced magnetic resonance imaging parameter based computer assisted diagnostic tool using three random variable co-occurrence approach.. 110–115. 1 indexed citations

17.

Wikström, Johan, Martin N.J.M. Wasser, Peter M. T. Pattynama, et al.. (2003). \nGadobenate dimeglumine-enhanced magnetic resonance angiography of the pelvic arteries.. Investigative Radiology. 38(8). 504–515. 4 indexed citations

18.

Wikström, Johan, Martin N.J.M. Wasser, Peter M. T. Pattynama, et al.. (2003). Gadobenate Dimeglumine-Enhanced Magnetic Resonance Angiography of the Pelvic Arteries. Investigative Radiology. 38(8). 504–515. 28 indexed citations

19.

Knopp, Michael V., Hendrik von Tengg‐Kobligk, F. Floemer, & Stefan O. Schoenberg. (1999). Contrast agents for MRA: Future directions. Journal of Magnetic Resonance Imaging. 10(3). 314–316. 55 indexed citations

20.

Schlemmer, HP, Thomas Heß, Jürgen Debus, et al.. (1994). TOF-MR-ANGIOGRAPHIE BEI STRAHLENTHERAPEUTISCH BEHANDELTEN ZEREBRALEN ARTERIOVENOSEN MALFORMATIONEN. Der Radiologe. 34(8). 447–453. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact